SWA
APLT

Stratos Wealth Advisors’s Applied Therapeutics APLT Stock Holding History

Stratos Wealth Advisors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,500
Closed -$6.35K – 658
2025
Q3 		$6.35K Sell
10,500
-1,605
-13% -$756 ﹤0.01% 677
2025
Q2 		$3.77K Buy
+12,105
New +$4.68K ﹤0.01% 669

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Stratos Wealth Advisors's APLT Position: Q4 2025 in Review

Stratos Wealth Advisors sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 10,500 shares — an estimated $6.35K sold.

Stratos Wealth Advisors first reported a position in APLT in Q2 2025 and held it in 2 quarters. The position peaked at $6.35K in Q3 2025. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

  • Stratos Wealth Advisors reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Stratos Wealth Advisors sold 10,500 Applied Therapeutics shares in Q4 2025, an estimated $6.35K.
  • Stratos Wealth Advisors first reported a position in Applied Therapeutics in Q2 2025 and held it in 2 quarters.
  • Stratos Wealth Advisors's Applied Therapeutics position peaked at $6.35K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Stratos Wealth Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.